CN Stock MarketDetailed Quotes

300357 Zhejiang Wolwo Bio-Pharmaceutical

Watchlist
  • 23.66
  • +0.03+0.13%
Market Closed May 31 15:00 CST
12.39BMarket Cap39.11P/E (TTM)

Zhejiang Wolwo Bio-Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Assets
Current assets
Money funds
29.86%1.2B
39.34%1.17B
36.41%1.07B
58.01%1.18B
27.41%920.42M
29.34%840.69M
26.65%782.49M
8.32%748.29M
-2.73%722.4M
11.36%649.99M
Transactional financial assets
-62.33%87.79M
-60.22%117.39M
-61.04%116.48M
-70.24%91.84M
-28.89%233.07M
-20.46%295.05M
-4.32%298.97M
46.25%308.61M
43.66%327.77M
20.81%370.93M
Notes receivable and accounts receivable
-11.70%188.03M
-36.46%161.58M
-5.34%276.22M
-2.00%218.21M
-5.51%212.95M
6.80%254.31M
8.08%291.8M
9.44%222.67M
23.72%225.37M
15.16%238.12M
-Notes receivable
-73.66%11.78M
-77.62%18.62M
-11.22%55.76M
-4.65%52.29M
-23.40%44.71M
1.46%83.21M
7.54%62.81M
46.65%54.84M
60.96%58.37M
13.10%82.01M
-Accounts receivable
4.76%176.26M
-16.45%142.96M
-3.73%220.46M
-1.14%165.92M
0.74%168.25M
9.60%171.1M
8.23%228.99M
1.06%167.83M
14.47%167.01M
16.28%156.11M
Other receivables (including interest and dividends)
-68.71%7.2M
-68.72%6.2M
27.69%21.47M
29.26%20.6M
81.09%23.01M
77.99%19.81M
21.01%16.81M
28.53%15.93M
13.58%12.71M
29.82%11.13M
-Other receivable
----
----
----
29.26%20.6M
----
77.99%19.81M
----
28.53%15.93M
----
29.82%11.13M
Advance payment
-70.93%5.34M
-46.07%5.82M
11.65%11.41M
-4.47%11.88M
83.16%18.38M
56.04%10.79M
15.29%10.22M
61.28%12.43M
83.65%10.04M
43.59%6.91M
Inventories
18.74%60.09M
21.95%59.04M
17.13%55.39M
6.30%53.14M
4.37%50.61M
-9.94%48.41M
-8.08%47.29M
-2.35%49.99M
-2.89%48.49M
11.21%53.75M
Receivable financing
--39.17M
--41.34M
----
----
----
----
----
----
----
----
Other current assets
127.17%12.78M
-11.30%7.16M
461.82%15.72M
171.64%11.78M
-58.38%5.62M
-24.34%8.07M
-74.65%2.8M
-71.59%4.34M
-1.44%13.51M
-6.15%10.66M
Total current assets
8.99%1.6B
6.28%1.57B
7.84%1.56B
16.70%1.59B
7.63%1.46B
10.11%1.48B
12.82%1.45B
14.30%1.36B
10.30%1.36B
14.60%1.34B
Non Current assets
Other equity investment
--5.4M
----
----
----
----
----
----
----
----
----
Investment real estate
----
----
--10.82M
----
----
----
----
----
----
----
Long-term equity investment
-5.01%73.72M
-5.34%74.21M
-7.68%74.6M
-6.96%76.46M
-6.54%77.61M
-5.94%78.4M
-4.98%80.8M
--82.18M
--83.05M
--83.35M
Fixed assets
----
----
----
32.60%196.59M
----
32.20%201.9M
----
-5.49%148.26M
----
-4.37%152.73M
Constru in process
----
----
----
105.13%360.2M
----
61.22%226.24M
----
74.19%175.6M
----
74.42%140.33M
Intangible assets
14.98%158.17M
15.55%161.38M
15.82%164.52M
53.32%167.56M
23.39%137.57M
48.58%139.67M
47.77%142.04M
11.24%109.29M
11.08%111.49M
54.08%94M
Development expenditure
-46.95%28.1M
-45.74%27.04M
-72.81%24.51M
-76.34%20.69M
-38.03%52.98M
-39.49%49.83M
16.61%90.15M
17.70%87.46M
20.74%85.49M
-24.74%82.35M
Long deferred expense
49.74%6.89M
117.91%7.34M
124.69%7.03M
94.76%5.93M
49.69%4.6M
-8.87%3.37M
0.30%3.13M
-15.16%3.04M
-23.52%3.08M
-17.43%3.7M
Deferred tax assets
7.09%5.23M
3.34%5.03M
-8.16%6.07M
-5.47%5.45M
-17.29%4.89M
-16.13%4.87M
2.04%6.61M
-2.88%5.77M
2.85%5.91M
18.63%5.81M
Usufruct assets
35.96%26.81M
72.35%28.37M
27.75%23.3M
230.35%17.99M
196.06%19.72M
92.40%16.46M
157.96%18.24M
-31.02%5.45M
-25.92%6.66M
-15.95%8.56M
Other non current assets
--13.01M
--12.42M
----
----
----
----
----
----
----
--19.63M
Total non current assets
29.59%1.03B
37.67%992.27M
35.95%946.59M
37.90%850.88M
29.69%793.66M
22.07%720.74M
22.56%696.27M
28.24%617.04M
33.95%611.97M
32.99%590.45M
Total assets
16.23%2.62B
16.57%2.56B
16.96%2.51B
23.31%2.44B
14.47%2.26B
13.76%2.2B
15.81%2.15B
18.31%1.98B
16.69%1.97B
19.66%1.93B
Liabilities
Current liabilities
Short term loan
145.87%49.17M
--34.39M
--14.67M
--27.33M
--20M
----
----
----
----
----
Notes payable and accounts payable
39.37%7.49M
4.03%7.99M
-10.32%7.73M
-24.05%6.46M
4.69%5.37M
51.09%7.68M
69.48%8.62M
43.66%8.51M
-9.43%5.13M
-10.22%5.08M
-Accounts payable
39.37%7.49M
4.03%7.99M
-10.32%7.73M
-24.05%6.46M
4.69%5.37M
51.09%7.68M
69.48%8.62M
43.66%8.51M
-9.43%5.13M
-10.22%5.08M
Contract liabilities
446.92%1.5M
-8.21%384.28K
-32.89%226.28K
-77.57%336.46K
-58.45%273.72K
0.28%418.64K
13.00%337.16K
369.57%1.5M
21.20%658.8K
-5.41%417.46K
Salaries payable
3.41%19.75M
9.77%29.04M
3.33%25.67M
6.53%19.02M
10.77%19.1M
11.61%26.45M
22.08%24.85M
8.93%17.85M
8.30%17.24M
17.10%23.7M
Taxs payable
11.44%19.03M
-52.16%14.5M
1.25%29.78M
-47.43%18.7M
-28.11%17.08M
-51.83%30.31M
-40.14%29.41M
103.67%35.58M
-11.77%23.76M
382.78%62.93M
Other payable (including interest and dividends)
118.01%57.76M
147.58%83.94M
182.73%82.43M
709.10%141.61M
235.36%26.5M
238.89%33.9M
181.17%29.15M
25.86%17.5M
-29.55%7.9M
-37.63%10M
-Dividend payable
----
----
----
--104.72M
----
----
----
----
----
----
-Other payable
----
----
----
110.81%36.9M
----
238.89%33.9M
----
25.86%17.5M
----
-37.63%10M
Non current liabilities due within one year
28.69%7.21M
70.73%6.8M
25.13%7.53M
-6.40%4.82M
14.39%5.6M
-32.07%3.98M
32.05%6.01M
17.61%5.15M
4.71%4.9M
15.07%5.86M
Total current liabilities
72.39%161.92M
72.30%177.04M
70.79%168.03M
153.56%218.29M
57.62%93.92M
-4.86%102.75M
9.56%98.38M
47.45%86.09M
-8.25%59.59M
78.47%108M
Current liabilities
Deferred tax liabilities
126.76%202.25K
158.41%203.24K
-59.14%248.96K
-62.28%159.46K
-89.24%89.19K
-84.23%78.65K
-91.40%609.31K
176.33%422.71K
378.41%828.88K
-10.49%498.87K
Long term deferred income
11.67%30.49M
12.77%30.93M
27.52%31.31M
28.05%31.59M
10.14%27.31M
10.09%27.43M
-1.94%24.55M
-1.93%24.67M
-1.92%24.79M
20.76%24.91M
Lease liabilities
38.07%19.53M
73.06%21.26M
17.03%14.97M
2,413.15%12.61M
853.77%14.14M
530.86%12.28M
627.14%12.79M
-82.29%501.72K
-62.12%1.48M
-58.73%1.95M
Other non current liabilities
2.87%29.03M
2.87%29.03M
--28.22M
--28.22M
--28.22M
--28.22M
----
----
----
----
Total non current liabilities
13.61%79.25M
19.72%81.42M
96.95%74.75M
183.56%72.58M
157.37%69.76M
148.57%68.01M
12.03%37.95M
-9.05%25.6M
-7.70%27.1M
5.61%27.36M
Total liabilities
47.34%241.17M
51.36%258.46M
78.08%242.77M
160.43%290.87M
88.81%163.68M
26.16%170.76M
10.24%136.33M
29.08%111.69M
-8.08%86.69M
56.63%135.36M
Shareholders equity
Paid-in capital
0.00%523.58M
0.00%523.58M
0.00%523.58M
0.00%523.58M
0.00%523.58M
0.00%523.58M
0.00%523.58M
0.00%523.58M
0.00%523.58M
0.00%523.58M
Capital reserve funds
0.00%128.19M
0.00%128.19M
0.00%128.19M
0.00%128.19M
0.00%128.19M
0.00%128.19M
0.00%128.19M
0.00%128.19M
0.00%128.19M
0.00%128.19M
Surplus reserve funds
15.14%270.72M
15.14%270.72M
20.79%235.12M
20.79%235.12M
20.79%235.12M
20.79%235.12M
24.97%194.65M
24.97%194.65M
24.97%194.65M
24.97%194.65M
Retained profit
15.19%1.34B
15.55%1.26B
13.17%1.26B
17.71%1.14B
18.52%1.16B
22.83%1.09B
29.49%1.11B
35.78%965.48M
36.69%981.37M
37.40%889.64M
Other composite income
26,045.83%5.38M
16.29%30.85K
14.85%34.64K
170.46%36.09K
1,275.44%20.57K
5,183.97%26.53K
412.14%30.16K
-98.46%13.34K
-100.20%-1.75K
-99.94%502.08
Shareholders equity without minority interests
10.62%2.27B
10.38%2.19B
9.55%2.14B
11.67%2.02B
12.16%2.05B
14.03%1.98B
17.53%1.96B
19.25%1.81B
19.75%1.83B
19.24%1.74B
Minority interests
161.90%115.32M
149.76%118.61M
135.28%122.9M
126.90%126.38M
-23.78%44.03M
-21.55%47.49M
-18.30%52.24M
-16.89%55.7M
-16.89%57.77M
-16.20%60.54M
Total shareholder equity
13.80%2.38B
13.64%2.3B
12.81%2.27B
15.11%2.15B
11.06%2.09B
12.83%2.03B
16.21%2.01B
17.72%1.87B
18.15%1.89B
17.57%1.8B
Total liabilityies and equity
16.23%2.62B
16.57%2.56B
16.96%2.51B
23.31%2.44B
14.47%2.26B
13.76%2.2B
15.81%2.15B
18.31%1.98B
16.69%1.97B
19.66%1.93B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Ernst & Young (Special General Partnership)
--
--
--
Ernst & Young (Special General Partnership)
--
--
--
Ernst & Young (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Assets
Current assets
Money funds 29.86%1.2B39.34%1.17B36.41%1.07B58.01%1.18B27.41%920.42M29.34%840.69M26.65%782.49M8.32%748.29M-2.73%722.4M11.36%649.99M
Transactional financial assets -62.33%87.79M-60.22%117.39M-61.04%116.48M-70.24%91.84M-28.89%233.07M-20.46%295.05M-4.32%298.97M46.25%308.61M43.66%327.77M20.81%370.93M
Notes receivable and accounts receivable -11.70%188.03M-36.46%161.58M-5.34%276.22M-2.00%218.21M-5.51%212.95M6.80%254.31M8.08%291.8M9.44%222.67M23.72%225.37M15.16%238.12M
-Notes receivable -73.66%11.78M-77.62%18.62M-11.22%55.76M-4.65%52.29M-23.40%44.71M1.46%83.21M7.54%62.81M46.65%54.84M60.96%58.37M13.10%82.01M
-Accounts receivable 4.76%176.26M-16.45%142.96M-3.73%220.46M-1.14%165.92M0.74%168.25M9.60%171.1M8.23%228.99M1.06%167.83M14.47%167.01M16.28%156.11M
Other receivables (including interest and dividends) -68.71%7.2M-68.72%6.2M27.69%21.47M29.26%20.6M81.09%23.01M77.99%19.81M21.01%16.81M28.53%15.93M13.58%12.71M29.82%11.13M
-Other receivable ------------29.26%20.6M----77.99%19.81M----28.53%15.93M----29.82%11.13M
Advance payment -70.93%5.34M-46.07%5.82M11.65%11.41M-4.47%11.88M83.16%18.38M56.04%10.79M15.29%10.22M61.28%12.43M83.65%10.04M43.59%6.91M
Inventories 18.74%60.09M21.95%59.04M17.13%55.39M6.30%53.14M4.37%50.61M-9.94%48.41M-8.08%47.29M-2.35%49.99M-2.89%48.49M11.21%53.75M
Receivable financing --39.17M--41.34M--------------------------------
Other current assets 127.17%12.78M-11.30%7.16M461.82%15.72M171.64%11.78M-58.38%5.62M-24.34%8.07M-74.65%2.8M-71.59%4.34M-1.44%13.51M-6.15%10.66M
Total current assets 8.99%1.6B6.28%1.57B7.84%1.56B16.70%1.59B7.63%1.46B10.11%1.48B12.82%1.45B14.30%1.36B10.30%1.36B14.60%1.34B
Non Current assets
Other equity investment --5.4M------------------------------------
Investment real estate ----------10.82M----------------------------
Long-term equity investment -5.01%73.72M-5.34%74.21M-7.68%74.6M-6.96%76.46M-6.54%77.61M-5.94%78.4M-4.98%80.8M--82.18M--83.05M--83.35M
Fixed assets ------------32.60%196.59M----32.20%201.9M-----5.49%148.26M-----4.37%152.73M
Constru in process ------------105.13%360.2M----61.22%226.24M----74.19%175.6M----74.42%140.33M
Intangible assets 14.98%158.17M15.55%161.38M15.82%164.52M53.32%167.56M23.39%137.57M48.58%139.67M47.77%142.04M11.24%109.29M11.08%111.49M54.08%94M
Development expenditure -46.95%28.1M-45.74%27.04M-72.81%24.51M-76.34%20.69M-38.03%52.98M-39.49%49.83M16.61%90.15M17.70%87.46M20.74%85.49M-24.74%82.35M
Long deferred expense 49.74%6.89M117.91%7.34M124.69%7.03M94.76%5.93M49.69%4.6M-8.87%3.37M0.30%3.13M-15.16%3.04M-23.52%3.08M-17.43%3.7M
Deferred tax assets 7.09%5.23M3.34%5.03M-8.16%6.07M-5.47%5.45M-17.29%4.89M-16.13%4.87M2.04%6.61M-2.88%5.77M2.85%5.91M18.63%5.81M
Usufruct assets 35.96%26.81M72.35%28.37M27.75%23.3M230.35%17.99M196.06%19.72M92.40%16.46M157.96%18.24M-31.02%5.45M-25.92%6.66M-15.95%8.56M
Other non current assets --13.01M--12.42M------------------------------19.63M
Total non current assets 29.59%1.03B37.67%992.27M35.95%946.59M37.90%850.88M29.69%793.66M22.07%720.74M22.56%696.27M28.24%617.04M33.95%611.97M32.99%590.45M
Total assets 16.23%2.62B16.57%2.56B16.96%2.51B23.31%2.44B14.47%2.26B13.76%2.2B15.81%2.15B18.31%1.98B16.69%1.97B19.66%1.93B
Liabilities
Current liabilities
Short term loan 145.87%49.17M--34.39M--14.67M--27.33M--20M--------------------
Notes payable and accounts payable 39.37%7.49M4.03%7.99M-10.32%7.73M-24.05%6.46M4.69%5.37M51.09%7.68M69.48%8.62M43.66%8.51M-9.43%5.13M-10.22%5.08M
-Accounts payable 39.37%7.49M4.03%7.99M-10.32%7.73M-24.05%6.46M4.69%5.37M51.09%7.68M69.48%8.62M43.66%8.51M-9.43%5.13M-10.22%5.08M
Contract liabilities 446.92%1.5M-8.21%384.28K-32.89%226.28K-77.57%336.46K-58.45%273.72K0.28%418.64K13.00%337.16K369.57%1.5M21.20%658.8K-5.41%417.46K
Salaries payable 3.41%19.75M9.77%29.04M3.33%25.67M6.53%19.02M10.77%19.1M11.61%26.45M22.08%24.85M8.93%17.85M8.30%17.24M17.10%23.7M
Taxs payable 11.44%19.03M-52.16%14.5M1.25%29.78M-47.43%18.7M-28.11%17.08M-51.83%30.31M-40.14%29.41M103.67%35.58M-11.77%23.76M382.78%62.93M
Other payable (including interest and dividends) 118.01%57.76M147.58%83.94M182.73%82.43M709.10%141.61M235.36%26.5M238.89%33.9M181.17%29.15M25.86%17.5M-29.55%7.9M-37.63%10M
-Dividend payable --------------104.72M------------------------
-Other payable ------------110.81%36.9M----238.89%33.9M----25.86%17.5M-----37.63%10M
Non current liabilities due within one year 28.69%7.21M70.73%6.8M25.13%7.53M-6.40%4.82M14.39%5.6M-32.07%3.98M32.05%6.01M17.61%5.15M4.71%4.9M15.07%5.86M
Total current liabilities 72.39%161.92M72.30%177.04M70.79%168.03M153.56%218.29M57.62%93.92M-4.86%102.75M9.56%98.38M47.45%86.09M-8.25%59.59M78.47%108M
Current liabilities
Deferred tax liabilities 126.76%202.25K158.41%203.24K-59.14%248.96K-62.28%159.46K-89.24%89.19K-84.23%78.65K-91.40%609.31K176.33%422.71K378.41%828.88K-10.49%498.87K
Long term deferred income 11.67%30.49M12.77%30.93M27.52%31.31M28.05%31.59M10.14%27.31M10.09%27.43M-1.94%24.55M-1.93%24.67M-1.92%24.79M20.76%24.91M
Lease liabilities 38.07%19.53M73.06%21.26M17.03%14.97M2,413.15%12.61M853.77%14.14M530.86%12.28M627.14%12.79M-82.29%501.72K-62.12%1.48M-58.73%1.95M
Other non current liabilities 2.87%29.03M2.87%29.03M--28.22M--28.22M--28.22M--28.22M----------------
Total non current liabilities 13.61%79.25M19.72%81.42M96.95%74.75M183.56%72.58M157.37%69.76M148.57%68.01M12.03%37.95M-9.05%25.6M-7.70%27.1M5.61%27.36M
Total liabilities 47.34%241.17M51.36%258.46M78.08%242.77M160.43%290.87M88.81%163.68M26.16%170.76M10.24%136.33M29.08%111.69M-8.08%86.69M56.63%135.36M
Shareholders equity
Paid-in capital 0.00%523.58M0.00%523.58M0.00%523.58M0.00%523.58M0.00%523.58M0.00%523.58M0.00%523.58M0.00%523.58M0.00%523.58M0.00%523.58M
Capital reserve funds 0.00%128.19M0.00%128.19M0.00%128.19M0.00%128.19M0.00%128.19M0.00%128.19M0.00%128.19M0.00%128.19M0.00%128.19M0.00%128.19M
Surplus reserve funds 15.14%270.72M15.14%270.72M20.79%235.12M20.79%235.12M20.79%235.12M20.79%235.12M24.97%194.65M24.97%194.65M24.97%194.65M24.97%194.65M
Retained profit 15.19%1.34B15.55%1.26B13.17%1.26B17.71%1.14B18.52%1.16B22.83%1.09B29.49%1.11B35.78%965.48M36.69%981.37M37.40%889.64M
Other composite income 26,045.83%5.38M16.29%30.85K14.85%34.64K170.46%36.09K1,275.44%20.57K5,183.97%26.53K412.14%30.16K-98.46%13.34K-100.20%-1.75K-99.94%502.08
Shareholders equity without minority interests 10.62%2.27B10.38%2.19B9.55%2.14B11.67%2.02B12.16%2.05B14.03%1.98B17.53%1.96B19.25%1.81B19.75%1.83B19.24%1.74B
Minority interests 161.90%115.32M149.76%118.61M135.28%122.9M126.90%126.38M-23.78%44.03M-21.55%47.49M-18.30%52.24M-16.89%55.7M-16.89%57.77M-16.20%60.54M
Total shareholder equity 13.80%2.38B13.64%2.3B12.81%2.27B15.11%2.15B11.06%2.09B12.83%2.03B16.21%2.01B17.72%1.87B18.15%1.89B17.57%1.8B
Total liabilityies and equity 16.23%2.62B16.57%2.56B16.96%2.51B23.31%2.44B14.47%2.26B13.76%2.2B15.81%2.15B18.31%1.98B16.69%1.97B19.66%1.93B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Ernst & Young (Special General Partnership)------Ernst & Young (Special General Partnership)------Ernst & Young (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg